通过外泌体介导的miR-93-TXNIP-NLRP3细胞焦亡导致M1及M2型巨噬细胞在脓毒症相关性急性肾损伤中功能差别的研究
批准号:
81970579
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
周国平
依托单位:
学科分类:
泌尿系统损伤与修复
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
周国平
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
脓毒症相关急性肾损伤(SA-AKI)死亡率高,但机制未明确。细胞焦亡在AKI中起重要作用。MФ 与肾小管上皮细胞(TECs)通过交互作用影响SA-AKI进程。我们发现:M1、M2型巨噬细胞与TECs共培养,M1型加重细胞焦亡,M2型减轻细胞焦亡;M1、M2型巨噬细胞分泌的外泌体与TECs共培养,M1型加重细胞焦亡,M2型减轻细胞焦亡;miR-93在M1中低表达,在M2中高表达;细胞焦亡通路相关蛋白TXNIP是miR-93的靶基因。因此我们提出假说:MФ 分化的M1、M2不同表型可导致AKI细胞功能差异;M2外泌体中高表达的miR-93可抑制细胞焦亡。本课题将利用芯片筛选、生物信息学分析和细胞功能验证等方法,从体外细胞分子、体内动物实验水平阐明通过外泌体介导的miR-93-TXNIP-NLRP3细胞焦亡导致M1及M2型巨噬细胞在脓毒症相关急性肾损伤中功能差别的机制,为AKI治疗提供新思路。
英文摘要
The mortality of sepsis-associated acute kidney injury (SA-AKI) is high, but the mechanism is not clear. Pyroptosis plays an important role in AKI. MФ interacts with renal tubular epithelial cells (TECs) to influence the SA-AKI process. We found that when M1 and M2 macrophages were co-cultured with TECs, M1 type aggravated pyroptosis, M2 type attenuated pyroptosis. When M1 and M2 macrophages secreted exosomes were co-cultured with TECs, M1 type aggravated pyroptosis, the M2 type attenuated pyroptosis. The miR-93 was lowly expressed in M1 type and highly expressed in M2 type. The pyroptosis related protein TXNIP was the miR-93 target gene. Therefore, we propose a hypothesis: MФ differentiated M1 and M2 phenotypes may lead to functional differences in AKI cells. The miR-93, which is highly expressed in M2 type exosomes, inhibits pyroptosis. This project will use microarray screening, bioinformatics analysis, cell function verification and other methods to elucidate the functional difference of M1 and M2 macrophages in sepsis-associated acute kidney injury induced by exosomes-mediated miR-93-TXNIP-NLRP3 pyroptosis via in vitro cellular and in vivo animal experiments. This mechanism study will provide new ideas for AKI treatment.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:DOI: 10.3389/fgene.2022.973319
发表时间:2022
期刊:Front Genet (中科院3区,影响因子 4.772)
影响因子:--
作者:Yan Mao;Zhengyun Hu;Xuejiao Xu;Jinwen Xu;Chuyan Wu;Feng Jiang;Guoping Zhou
通讯作者:Guoping Zhou
DOI:10.1111/jcmm.15661
发表时间:2020-09
期刊:Journal of cellular and molecular medicine
影响因子:5.3
作者:Chen JH;Feng DD;Chen YF;Yang CX;Juan CX;Cao Q;Chen X;Liu S;Zhou GP
通讯作者:Zhou GP
DOI:10.7150/ijbs.78348
发表时间:2023
期刊:International journal of biological sciences
影响因子:9.2
作者:Mao Y;Jiang F;Xu XJ;Zhou LB;Jin R;Zhuang LL;Juan CX;Zhou GP
通讯作者:Zhou GP
DOI:10.1016/j.molimm.2023.06.008
发表时间:2023-06
期刊:Molecular immunology
影响因子:3.6
作者:D. Feng;Jia-He Chen;Yu-fei Chen;Q. Cao;Bingjie Li;Xiao‐qing Chen;R. Jin;Guo-Ping Zhou
通讯作者:D. Feng;Jia-He Chen;Yu-fei Chen;Q. Cao;Bingjie Li;Xiao‐qing Chen;R. Jin;Guo-Ping Zhou
DOI:10.1111/jcmm.16449
发表时间:2021-05
期刊:Journal of cellular and molecular medicine
影响因子:5.3
作者:Juan CX;Mao Y;Cao Q;Chen Y;Zhou LB;Li S;Chen H;Chen JH;Zhou GP;Jin R
通讯作者:Jin R
维甲酸调控CD2AP转录水平的分子机制
- 批准号:81170661
- 项目类别:面上项目
- 资助金额:58.0万元
- 批准年份:2011
- 负责人:周国平
- 依托单位:
干扰素调节因子3多个启动子及其剪接异构体的特性
- 批准号:30872804
- 项目类别:面上项目
- 资助金额:34.0万元
- 批准年份:2008
- 负责人:周国平
- 依托单位:
与肾小球疾病关联的CD2相关蛋白基因转录调控研究
- 批准号:30570863
- 项目类别:面上项目
- 资助金额:25.0万元
- 批准年份:2005
- 负责人:周国平
- 依托单位:
国内基金
海外基金















{{item.name}}会员


